Attorneys Report Agreement For Paxil Birth Defect MDL

Top Quote reports that there has been an apparent agreement between attorneys for Glaxo SmithKline and attorneys representing several plaintiffs to file a joint motion requesting the formation of an MDL or multidistrict litigation for all pending Federal Paxil birth defect claims. End Quote
  • New York, NY (1888PressRelease) January 09, 2009 - It has been reported from an anonymous source that there may be an agreement between attorneys representing Glaxo SmithKline and a group of attorneys representing plaintiffs to file a joint motion before the United States Judicial Panel on Multidistrict Litigation, requesting that all Paxil birth defect cases currently pending in the Federal courts be consolidated in a MDL before the Honorable Eldon E Fallon of the Eastern District of Louisiana. Judge Fallon is currently overseeing the Vioxx litigation in MDL 1657.

    The filing of an MDL could result in a flood of new filing by plaintiffs. Paxil has been alleged to be the cause of significant heart defects in newborns exposed during pregnancy. Several hundred cases have been filed against the manufacturer, Glaxo SmithKline, “GSK”.

    The formation of an MDL may result in a flood of new case filings., reports that Glaxo continues to market their product and advises against discontinuing use of Paxil during pregnancy despite the increased risk of birth defects.

    If you or someone you know suffers from an injury, birth defects or other side effects, or if you have lost a loved one due to these dangers, you are not alone and you deserve answers. Make sure to contact the experienced, and knowledgeable birth defect lawyers at

  • FB Icon Twitter Icon In-Icon
Contact Information